CAS Number: 201943-63-7
the massive cell lysis associated with the treatment of some malignancies
) dramatically decreases blood cholesterol and modifies the hepatic cholesterol pattern via enhancing the free/esterified cholesterol ratio
is a novel orally bioavailable inhibitor against a broad spectrum of Bcr-Abl mutants including T315I
InChiKey: HLXSCTYHLQHQDJ-UHFFFAOYSA-N
2''-O-Rhamnosylicariside II 11217 CAS Number: 201943-63-72'' O Rhamnosylicariside II is a flavonoid glycoside compound and might be beneficial for improving postmenopausal osteoporosis. Product information CAS Number: 135293 13 9 Molecular Weight: 660. 66 Formula: C33H40O14 Chemical Name: 3 {[(2S,3R,4R,5R,6S) 4,5 dihydroxy 6 methyl 3 {[(2S,3R,4R,5R,6S) 3,4,5 trihydroxy 6 methyloxan 2 yl]oxy}oxan 2 yl]oxy} 5,7 dihydroxy 2 (4 methoxyphenyl) 8 (3 methylbut 2 en 1 yl) 4H chromen 4 one Smiles: